TOP NEWS
BSE

SME IPO: Broach Lifecare Shares Debut at 90% Premium, Surges Further on BSE Listing

August 21, 2024 New Delhi, India SME IPO Broach Lifecare Hospital made a remarkable debut on the Bombay Stock Exchange (BSE) on Wednesday, August 21, as its shares listed at a 90% premium over the issue price. Following a highly successful initial public offering (IPO), the shares opened at ₹47.50, significantly higher than the issue…

Read More
USDINR

IPO Listing: Ceigall India Shares List At 4.4% Premium To Issue Price On NSE, 3% Premium On The BSE

August 8, 2024 New Delhi, India Ceigall India IPO Listing Ceigall India Limited’s shares made a moderate debut on the stock exchanges, listing at a premium to the issue price. The IPO had garnered significant interest, reflected in its high subscription rates. Listing Details: NSE Listing: Shares listed at ₹419, a 4.5% premium over the…

Read More
Indian Stock Market

BSE Share Price Surges 8% Following Rating Upgrade by Investec, Predicts 38% Upside Potential

March 22, 2023 New Delhi, India BSE Shares Surged By 8% In a significant development, the share price of the Bombay Stock Exchange (BSE) witnessed a remarkable surge of nearly 8% today following a rating upgrade from brokerage firm Investec. Here are the key highlights from this event: Rating Upgrade and Target Price: Investec upgraded…

Read More
Dr Reddy's Laboratories

Dr Reddy’s Laboratories Faces Share Slump 7% After FDA’s Severe Observations

December 11, 2023 New Delhi, India Dr Reddy’s Laboratories Shares Shares of pharmaceutical giant Dr Reddy’s Laboratories witnessed a sharp decline of nearly 7% following “severe” observations from the US Food and Drug Administration (FDA) regarding its unit in Telangana. This development raises concerns about the company’s US revenue, with the Bachupally unit playing a…

Read More